-transparent.png){kind=logo}
The tracer 123I-SCH 23982 was tested with regard to its ability to image dopamine D1 receptor in the human brain in vivo with single photon emission computed tomography (SPECT). The tracer did not reach equilibrium with regard to its binding to dopamine D1 receptors, presumably owing to fast metabolism to hydrophilic products and deiodination. It is concluded that 123I-SCH 23982 is not suitable for dopamine D1 receptor imaging with SPECT in the human brain.
Related Publications
N P Verhoeff, and
A Bekier, and
H F Beer, and
P A Schubiger, and
P Fennema, and
E A van Royen
June 1992,
International journal of radiation applications and instrumentation. Part A, Applied radiation and isotopes,
N P Verhoeff, and
A Bekier, and
H F Beer, and
P A Schubiger, and
P Fennema, and
E A van Royen
April 1987,
Brain research,
N P Verhoeff, and
A Bekier, and
H F Beer, and
P A Schubiger, and
P Fennema, and
E A van Royen
January 1990,
International journal of radiation applications and instrumentation. Part A, Applied radiation and isotopes,
N P Verhoeff, and
A Bekier, and
H F Beer, and
P A Schubiger, and
P Fennema, and
E A van Royen
June 1988,
Brain research,
N P Verhoeff, and
A Bekier, and
H F Beer, and
P A Schubiger, and
P Fennema, and
E A van Royen
July 1993,
Nuclear medicine and biology,
N P Verhoeff, and
A Bekier, and
H F Beer, and
P A Schubiger, and
P Fennema, and
E A van Royen
December 1994,
Journal of neurochemistry,
N P Verhoeff, and
A Bekier, and
H F Beer, and
P A Schubiger, and
P Fennema, and
E A van Royen
March 1989,
Biochemical pharmacology,
N P Verhoeff, and
A Bekier, and
H F Beer, and
P A Schubiger, and
P Fennema, and
E A van Royen
August 1988,
Journal of neurochemistry,
N P Verhoeff, and
A Bekier, and
H F Beer, and
P A Schubiger, and
P Fennema, and
E A van Royen
January 1989,
Synapse (New York, N.Y.),
N P Verhoeff, and
A Bekier, and
H F Beer, and
P A Schubiger, and
P Fennema, and
E A van Royen
September 1986,
European journal of pharmacology,
